Dr. Boris Heifets's research group is dedicated to understanding and improving on powerful, rapid-acting therapies for psychiatric disease, such as ketamine, MDMA and psilocybin. They bridge basic science and clinical trials, connecting neuroscience, psychiatry and anesthesiology in pursuit of highly effective, safe treatment strategies scalable to the millions of patients who need them.

Dr. Bomi Lee's lab is dedicated to unraveling the complexities of the immune microenvironment and its role in the pathogenesis of pancreatic diseases, such as pancreatitis and pancreatic cancer. By leveraging cutting-edge technology, innovative experimental and genetic animal models, as well as human specimens from donors, we aim to identify novel immune markers and potential therapeutic targets. Our goal is to advance the understanding of immune cells and their contributions to these diseases and to translate our findings into innovative treatments.

Home Department: Orthopaedic Surgery
Faculty Advisor: Fan Yang
Talk Title: Microribbon‐based hydrogels guided mesenchymal stem cells to undergo endochondral ossification in vivo
Event: Society for Biomaterials 2017 Annual Meeting - One of Bogdan's presentations was also awarded the Orthopaedic Biomaterials SIG Star Abstract Award and the SFB STAR Award, and the other presentation was a SFB STAR Honorable Mention.

Awarded in 2016
Talk Title: Microribbon-based hydrogels induced robust osteogenesis of mesenchymal stem cells and bone regeneration with enhanced mechanical strength
Event: 2016 Orthopaedic Research Society (ORS) Annual Meeting

Awarded in 2015
Talk Title: Macroporous Microribbon-Based Hydrogels Accelerate Neocartilage Formation By Mesenchymal Stem Cells In Vitro
Event: Annual Biomedical Engineering Society (BMES) Meeting 2015

Awarded in 2013
Home Department: Chemistry
Faculty Advisors: Hongjie Dai (Chemistry), Brian Feldman (Pediatrics), Paul Utz (Medicine), and Samuel Strober (Medicine)